abstract |
Inhibition of aggregation of superactivated platelets, blocking of activation of coagulation cascade, treatment of primary open-angle glaucoma, and treatment of microvascular diseases is effected by co-administration of a stilbene, a flavonol, and a μ-opioid receptor antagonist. |